Insulin LISPRO + Insulin, Long-Acting and Insulin
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Gestational Diabetes Mellitus
Conditions
Gestational Diabetes Mellitus
Trial Timeline
Oct 1, 2008 → Oct 1, 2010
NCT ID
NCT01613807About Insulin LISPRO + Insulin, Long-Acting and Insulin
Insulin LISPRO + Insulin, Long-Acting and Insulin is a approved stage product being developed by Eli Lilly for Gestational Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT01613807. Target conditions include Gestational Diabetes Mellitus.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01613807 | Approved | Completed |
Competing Products
18 competing products in Gestational Diabetes Mellitus
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| somatropin | Eli Lilly | Phase 3 | 77 |
| Camrelizumab plus apatinib CohortA + Camrelizumab plus apatinib Cohort B | Jiangsu Hengrui Medicine | Phase 2 | 52 |
| Pembrolizumab Injection [Keytruda] | Merck | Phase 2 | 52 |
| recombinant somatropin | Merck | Pre-clinical | 23 |
| Recombinant human growth hormone (r-hGH) | Merck | Phase 3 | 77 |
| Avelumab Injection + Methotrexate 1 GM Injection | Merck | Phase 1/2 | 41 |
| Saizen® + Saizen® | Merck | Phase 3 | 77 |
| Metformin + placebo | Novo Nordisk | Approved | 84 |
| Metformin XR plus placebo + Metformin XR plus liraglutide | Novo Nordisk | Phase 3 | 76 |
| Somapacitan + Norditropin® | Novo Nordisk | Phase 2 | 51 |
| Liraglutide + Placebo | Novo Nordisk | Approved | 84 |
| Genotropin (PN-180,307) Somatropin + Control-no treatment | Pfizer | Phase 3 | 76 |
| growth hormone | Pfizer | Pre-clinical | 22 |
| Somatropin | Pfizer | Pre-clinical | 22 |
| Somatropin | Pfizer | Pre-clinical | 22 |
| Genotropin (somatropin) | Pfizer | Approved | 84 |
| Omnitrope | Sandoz Group | Approved | 82 |
| Inhaled Technosphere Insulin | MannKind Corp | Phase 2/3 | 60 |